ASCO 2019: Dr. Koffman’s Pick #8 Second Cancers in Patients Receiving BTK Inhibitors in chronic lymphocytic leukemia (CLL)
December 7, 2019
What good does it do to survive our CLL, if we are going to die earlier of a second cancer? We already know that all chronic lymphocytic leukemia patients have compromised immune systems and as a result have a higher incidence of both infections and second cancers.
